Post-approval studies (Phase 4)Study completedNCT00108238What this trial is testingEstrogen Alternatives StudyWho this might be right forHealthy US Department of Veterans Affairs
Not applicableStudy completedNCT02218463What this trial is testingTreatment of Prepubertal Labial AdhesionsWho this might be right forPrepubertal Labial Adhesions Children's Mercy Hospital Kansas City 43
Post-approval studies (Phase 4)UnknownNCT02264743What this trial is testingOral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen TherapyWho this might be right forVenous ThrombosisInsulin Resistance Royal Brompton & Harefield NHS Foundation Trust 60
Large-scale testing (Phase 3)Study completedNCT00745108What this trial is testingTibolone Endometrium Study (Study 32972)(P06470)Who this might be right forPostmenopausal Women Organon and Co 32
Testing effectiveness (Phase 2)Ended earlyNCT04059484What this trial is testingPhase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast CancerWho this might be right forBreast Cancer Metastatic Sanofi 367
Testing effectiveness (Phase 2)Study completedNCT02197897What this trial is testingEvaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder TumorsWho this might be right forBladder Cancer Baylor College of Medicine 15
Large-scale testing (Phase 3)Active Not RecruitingNCT04975308What this trial is testingImlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast CancerWho this might be right forBreast NeoplasmsNeoplasm Metastasis Eli Lilly and Company 874
Large-scale testing (Phase 3)Study completedNCT00066690What this trial is testingSuppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast CancerWho this might be right forEstrogen Receptor Positive Breast CancerProgesterone Receptor Positive TumorRecurrent Breast Carcinoma+5 more ETOP IBCSG Partners Foundation 3,066
Testing effectiveness (Phase 2)Study completedNCT00463788What this trial is testingCetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast CancerWho this might be right forBreast Neoplasm Merck KGaA, Darmstadt, Germany 181
Large-scale testing (Phase 3)Looking for participantsNCT06905210What this trial is testingStudy of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne VulgarisWho this might be right forAcne VulgarisAcne Vulgaris on the Face Eurofarma Laboratorios S.A. 531
Not applicableUnknownNCT02977949What this trial is testingThe Effects of Seasonal Changes in Osteoporosis TreatmentWho this might be right forSelective Estrogen Receptor Modulator (SERM) Toshihiko Kono 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04692103What this trial is testingSerial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted TherapyWho this might be right forEstrogen Receptor PositivePrimary or Recurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7 University of Washington 2
Large-scale testing (Phase 3)Looking for participantsNCT06343870What this trial is testingEstradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)Who this might be right forMenopauseTestosterone DeficiencyEstrogen Deficiency University of Sao Paulo General Hospital 140
Large-scale testing (Phase 3)Study completedNCT01389102What this trial is testingEstradiol Transdermal Spray in the Treatment of Vasomotor SymptomsWho this might be right forHot Flashes Lumara Health, Inc. 454
Testing effectiveness (Phase 2)Study completedNCT02997995What this trial is testingDurvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant ExposureWho this might be right forBreast CancerEstrogen Receptor Positive TumorMenopause+1 more UNICANCER 61
Post-approval studies (Phase 4)Ended earlyNCT05183828What this trial is testingEffect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast CancerWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more University of Washington 62
Not applicableStudy completedNCT01064453What this trial is testingAngeliq Regulatory Post Marketing SurveillanceWho this might be right forPostmenopausal PeriodOsteoporosis, Postmenopausal Bayer 4,078
Testing effectiveness (Phase 2)Looking for participantsNCT07340541What this trial is testingEvolutionary Clinical Trial for Novel Biomarker-Driven TherapiesWho this might be right forBreast CancerMetastatic Breast CancerTriple Negative Breast Cancer+2 more UNC Lineberger Comprehensive Cancer Center 700
Not applicableStudy completedNCT00702858What this trial is testingTrial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast CancerWho this might be right forBreast CancerJoint Pain Legacy Health System 30
Testing effectiveness (Phase 2)Looking for participantsNCT06366347What this trial is testingALPINE: Maintenance Letrozole/AbemaciclibWho this might be right forEndometrial CancerRecurrent Endometrial CancerTP53 Dana-Farber Cancer Institute 32